首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1562471

感染疾病診斷市場規模、佔有率、成長分析、按產品/服務、按測試類型、按樣本類型、按疾病類型、按地區 - 行業預測，2024-2031 年

Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月11日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球感染疾病診斷市場規模為212億美元，從2023年的229.4億美元成長到2031年的430.9億美元，在預測期內（2024-2031年）預計將以複合年成長率成長。 %。

診斷測試在識別疾病和改善全球健康結果方面發揮關鍵作用。傳統的感染疾病診斷方法往往耗時且容易出現不準確的情況，為及時、準確的檢測帶來了重大挑戰。這項限制推動了感染疾病診斷市場的進步，導致快速、準確和攜帶式照護現場(POC) 檢測設備的發展。 POC 測試透過使測試過程更接近患者所在位置來實現快速診斷，並立即提供結果。這項創新大大提高了感染疾病檢測的效率，使其在緊急和遠距醫療保健中特別有價值。因此，許多研究人員現在專注於推進可以同時檢測多種病原體的多點護理診斷技術。這些進步透過提供更有效率、更準確的測試選項，正在改變感染疾病診斷的模式。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

F. Hoffmann-La Roche Ltd.（Switzerland）
Abbott（US）
bioMerieux（France）
Siemens Healthineers AG（Germany）
Danaher（US）
Thermo Fisher Scientific Inc.（US）
Hologic, Inc.（US）
Becton, Dickinson and Company（US）
Revvity（US）
Qiagen（Netherlands）
Seegene Inc.（South Korea）
QuidelOrtho Corporation（US）
Grifols, SA（Spain）
DiaSorin SpA（Italy）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
OraSure Technologies（US）
Co-Diagnostics, Inc.（US）
Trinity Biotech（Ireland）
Genetic Signatures Ltd.（Australia）
Epitope Diagnostics, Inc.（US）
Trivitron Healthcare（India）
ELITech Group（France）
Meril Life Sciences Pvt. Ltd.（India）
InBios International, Inc.（US）
Uniogen Oy（Finland）
Vela Diagnostics（Singapore）

簡介目錄

Product Code: SQMIG35G2215

Global Infectious Disease Diagnostics Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

Diagnostic tests play a crucial role in identifying diseases and enhancing global health outcomes. Traditional methods for diagnosing infectious diseases were often time-consuming and prone to inaccuracies, which created significant challenges in timely and accurate detection. This limitation has driven advancements in the Infectious Disease Diagnostics Market, leading to the development of rapid, precise, and portable point-of-care (POC) testing devices. POC testing enables quicker diagnosis by bringing the testing process closer to the patient's location, delivering immediate results. This innovation has significantly improved the efficiency of infectious disease detection, making it especially valuable in urgent or remote healthcare settings. As a result, many researchers are now focused on advancing multiplex point-of-care diagnostic technologies, which can simultaneously detect multiple pathogens. These advancements are transforming the landscape of infectious disease diagnostics, offering more efficient and accurate testing options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease Diagnostics Market Segmental Analysis

Global Infectious Disease Diagnostics Market is segmented by Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User, and region. Based on Product & Service, the market is segmented into Reagents, Kits, And Consumables, Instruments, Software & Services. Based on Type of Testing, the market is segmented into Laboratory Testing, POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Sample Types. Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, Other Infectious Diseases. Based on Technology, the market is segmented into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Other Technologies. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Infectious Disease Diagnostics Market

The rising prevalence of infectious diseases in both developed and developing regions is expected to positively influence the infectious disease diagnostics market. As more individuals seek diagnosis and treatment for such diseases, there has been a noticeable increase in prescriptions for diagnostic tests. This growing demand highlights the essential role of diagnostics in managing and addressing infectious health conditions. Additionally, the shift towards preventive medicine is further boosting the demand for infectious disease diagnostics. As healthcare providers and patients place greater emphasis on early detection and prevention, the use of diagnostic tests is anticipated to rise steadily over the forecast period. These combined factors are set to drive the market's expansion in the coming years.

Restraints in the Global Infectious Disease Diagnostics Market

Insufficient reimbursement poses a significant barrier to the growth of the infectious disease diagnostics market. Many diagnostic companies struggle with the challenge of securing coverage from health insurers for their tests, which complicates the commercialization process. This issue is particularly acute in developing countries, where a substantial portion of the population suffers from infectious diseases such as HIV, malaria, and tuberculosis. Additionally, the adoption of point-of-care (POC) kits in low- and middle-income countries is hindered by factors such as inadequate training for clinicians and limited product accessibility. These challenges are exacerbated by lower per capita healthcare expenditure in these regions, which contributes to the reduced uptake of advanced diagnostic technologies. As a result, addressing reimbursement issues and improving access and training are critical for enhancing the adoption of diagnostic solutions globally.

Market Trends of the Global Infectious Disease Diagnostics Market

Despite significant efforts in managing infectious diseases, there remains a strong demand for affordable, accurate, and sensitive point-of-care (POC) diagnostic products. The advent of nanotechnology has greatly contributed to advancements in this area, facilitating the development of innovative solutions in healthcare. Numerous companies are now focusing on integrating nanoparticles and nanodevices into POC platforms to meet this demand. These advancements in nanotechnology are enhancing the capabilities of diagnostic tools, making them more accessible and effective for widespread use in various healthcare settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Infectious Disease Diagnostics Market by Product & Service

Market Overview
Reagents, Kits, And Consumables
Instruments
Software & Services

Infectious Disease Diagnostics Market by Type of Testing

Market Overview
Laboratory Testing
POC Testing

Infectious Disease Diagnostics Market by Sample Type

Market Overview
Blood, Serum, And Plasma
Urine
Other Sample Types

Infectious Disease Diagnostics Market by Disease Type

Market Overview
Hepatitis
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Chlamydia Trachomatis
Neisseria Gonorrhea
Tuberculosis
Influenza
Syphilis
Other Infectious Diseases

Infectious Disease Diagnostics Market by Technology

Market Overview
Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Other Technologies

Infectious Disease Diagnostics Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Other End Users

Infectious Disease Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Co-Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetic Signatures Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epitope Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELITech Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InBios International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Uniogen Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vela Diagnostics (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments